3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
20
Melanoma
7
Sarcoma
3
Neoplasms
3
Lymphoma
3
Uveal Melanoma
2
Leiomyosarcoma
2
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Melanoma, Cutaneous Malignant
1
Lung Neoplasms
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Kidney Neoplasms
1
Immunotherapy
1
Hyperthermia
1
Colonic Neoplasms
1
Breast Neoplasms
1
Advanced Melanoma
1
Interventions
selinexor
1
repotrectinib
1
pembrolizumab
1
pazopanib
1
Trabectedin
1
Suspensions
1
Proton Therapy
1
Magnetic Resonance Spectroscopy
1
Ifosfamide
1
Histamine H2 Antagonists
1
Fluorodeoxyglucose F18
1
Famotidine
1
FAPI-46
1
Doxorubicin
1
Capsules
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solitary Fibrous Tumors
×
Dacarbazine
×
1 year
×
Clear all
No trials found.